Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$262,174
+$2,157 QoQ
Shares Held
724
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,656
of 3,149 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stockman Wealth Management, Inc. holds $51,758,933 across 8 Drug Manufacturers - General names. AMGN ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
169,661 | $21,801,438 | |
| 2 | GSK |
GSK plc
|
264,689 | $13,874,997 | |
| 3 | PFE |
Pfizer Inc
|
465,614 | $11,211,985 | |
| 4 | LLY |
ELI LILLY & Co
|
1,454 | $1,743,971 | |
| 5 | AZN |
Astrazeneca PLC
|
5,841 | $1,107,570 | |
| 6 | JNJ |
Johnson & Johnson
|
4,255 | $1,080,642 | |
| 7 | ABBV |
AbbVie Inc.
|
2,687 | $676,156 | |
| 8 | AMGN |
Amgen Inc
This page
|
724 | $262,174 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $262,174 | 724 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $260,017 | 739 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $202,055 | 716 | Shares | Sole | 2025-10-16 | |
| 2025-03-31 | $214,657 | 689 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $227,802 | 707 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $222,151 | 711 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||